Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 4 days ago
222 views
Shared 1 month ago
394 views
Shared 1 month ago
373 views
Shared 1 month ago
388 views
Shared 1 month ago
393 views
Shared 2 months ago
246 views
Shared 2 months ago
286 views
Shared 3 months ago
51K views
Shared 4 months ago
270 views
Shared 6 months ago
473K views
Shared 6 months ago
201 views
Shared 6 months ago
84 views
Shared 7 months ago
476 views
Shared 7 months ago
1.2K views
Shared 8 months ago
399 views
Shared 9 months ago
493 views
Shared 9 months ago
148 views
Shared 9 months ago
41K views
Shared 9 months ago
323 views
Shared 9 months ago
103K views
Shared 1 year ago
780 views
Shared 1 year ago
162 views
Shared 1 year ago
454 views
Shared 1 year ago
18K views
Shared 1 year ago
23K views
Shared 1 year ago
345 views
Shared 1 year ago
678 views
Shared 1 year ago
479 views